Abstract
Endocannabinoids (eCBs) are neurotransmitters derived from arachidonic acid. eCBs bind to cannabinoid receptors and participate in several brain functions, like motor functions. Alterations in the endocannabinoid system in patients with Parkinson´s Disease (PD) have been evaluated by determination of anandamide (AEA) and 2-arachidonoyl glycerol (2AG), two major eCBs, in biological samples…